Insights into Company Bills & Payments

AGI Greenpac ↗

📍 Kolkata, West Bengal, India Active NSE AGI CIN L51433WB1960PLC024539 Cement, Building Materials & Polymers
Search companies

Key Metrics of AGI Greenpac

Revenue₹2,665 Cr▲ 5.4% YoYFY 2025-26
EBITDA₹685 Cr▼ 0.5% YoY
Net profit₹352 Cr▲ 9.2% YoY
Net worth₹2,408 Cr▲ 14.8% YoY
Competitors10identified

About AGI Greenpac

Sectors

Cement, Building Materials & PolymersGlass & Glassware

Company details

Website
agi-greenpac.com
Registered office
2, Red Cross Place, Kolkata, Kolkata, In-wb, 700001
Listed
NSE: AGI · ₹653.15

Operational Areas of AGI Greenpac

Cement, Building Materials & Polymers›Glass & Glassware

Company summary

Entity details

CINL51433WB1960PLC024539
LEI code335800KWI6N6L28H2G76
State codeWB
PIN code700001
Current legal nameAGI GREENPAC
Classification—
Listing statusListed
Registration no.024539
Company age—
PAN—
CountryIndia
CityKolkata
StateWest Bengal
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code51433
Description of main activityWholesale trade and commission trade
Description of business activityWholesale trade and commission trade
SectorCement, Building Materials & Polymers · Glass & Glassware

Share price · NSE: AGI

AGI on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 08 Apr 2026 CARE AA- Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 months▲ 1 notch
Change since first rating on record▲ 1 notchsince Jan 2019
Rating actions131 up · 0 down
Liquidity (CARE)Strong

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
08 Apr 2026CAREReaffirmed AA-A1+Stable₹1,234 Cr View
08 Apr 2025CAREUpgraded (from A+) —A1+Developing₹1,234 Cr View
02 Apr 2024CAREWatch A+A1+Negative₹1,357 Cr View
27 Mar 2023CAREWatch A+A1+Negative₹1,357 Cr View
28 Feb 2023CAREReaffirmed A+A1+Stable₹1,357 Cr View
22 Mar 2022CAREReaffirmed A+A1+Stable₹1,730 Cr View
24 Jan 2022CAREOther ———— View
04 Jan 2022CAREReaffirmed A+A1+Stable₹3,460 Cr View
26 Jul 2021CAREReaffirmed A+A1+Stable₹3,000 Cr View
03 Mar 2021CAREReaffirmed A+A1+Stable₹1,436 Cr View
25 Feb 2021CAREOther ———— View
27 Feb 2020CAREReaffirmed A+A1+Stable₹1,394 Cr View
28 Jan 2019CAREReaffirmed A+A1+Stable₹1,594 Cr View

Credit strengths (CARE, Apr 2026)

+ Large scale of operations supported by strong market position in container glass

AGI Greenpac is the second-largest player in container glass segment in terms of installed capacity in the Indian organised glass packaging industry. However, over the recent few quarters, the company has been reporting higher revenue compared to the Hindusthan National Glass & Industries Limited (HNG), which has the highest stated installed capacities for container glass. Resultantly, the company’s total operating income (TOI) is large having recorded TOI of ₹2537 crore in FY25 and estimated at

+ Robust capital structure and debt coverage indicators

The net worth of the company stood at ₹2096 crore as on March 31, 2025 against ₹1,814 crore as on March 31, 2024. The company has significantly deleveraged itself in FY23 post divesting its building product division. Post that, the overall gearing (including letter of credit (LC)) strengthened gradually from 0.49x as on March 31, 2023 to 0. 26x as on March 31, 2025 and is estimated at ~0.20x as on March 31, 2026 supported by healthy accretion to reserves. With comfortable debt position and healt

+ Healthy profitability margins, expected to be sustained

In the last few years, the company has reported a steady improvement in its operating margins, driven by high-capacity utilisation, an effective fuel mix, and favourable demand-supply dynamics, leading to enhanced operational efficiencies. The PBILDT margin improved from 19% in FY23 to 24% in FY25, with a consistent upward trend from 19% in FY22 to 23% in FY24 and further to 24% in FY25. Going forward, margins are expected to remain in the range of 22%–24%.

+ Diversified customer profile

The company’s products cater to a large reputed diversified customer base (which includes names like United Breweries Limited, SABMiller India Limited, United Spirits Ltd, Coca-Cola, among others) with a product range covering flint, amber and green containers. The top 10 customers contribute ~64% of the net sales, reflecting moderate customer diversification considering 2 CARE Ratings Ltd. Press Release business-to-business transactions. The company’s plants are equipped to manufacture 5 ml to

Credit challenges

− Volatile input costs partially covered by pass-through mechanism with customers

Soda ash, which is a major raw material for manufacturing container glass, has been the key contributor to the raw material c ost. The soda ash cost has been volatile over the recent past with significant gains in FY23 and partial moderation observed in FY 24. In FY25, the soda ash continued its downward trajectory and reached pre-FY23 levels. Power and fuel cost is another significant cost-item for the company which shot up in FY22-FY23. The company in the past had undertaken capex to reduce th

− Working capital intensive operations driven largely by moderate inventory cycle and receivable cycle

The company’s operating cycle is ~60-70 days, largely considering inventory cycle of ~60-75 days and receivable cycles of 50-60 days. Since furnace in glass manufacturing needs to be continuously operated for better economies of production, the company needs to maintain raw material inventory. However, despite this, the company modestly utilises its fund-based working capital limits. Project execution risk The company has announced sizeable greenfield expansions, including a 500 TPD facility in

− Project execution risk

The company has announced sizeable greenfield expansions, including a 500 TPD facility in Madhya Pradesh (₹700 crore; COD by FY27) and entry into aluminium can manufacturing in Uttar Pradesh with a capacity of 1.6 billion units (₹900–1,000 crore; COD by October 2027). The capex will be funded through a mix of debt and internal accruals. Despite the elevated capex, the company’s capital structure is expected to remain comfortable, supported by healthy cash accruals

Could lead to an upgrade

• Significant increase in scale of operations, turnover above ₹4,000 crore with healthy operating margins, PBILDT margins of at least 20% on a sustained basis. • Timely completion and stabilisation of capex

Could lead to a downgrade

• Sustained adverse impact in business risk profile, turnover below ₹2,000 crore and/or operating margins (PBILDT) below 15%. • Any significant debt programme or moderation in operating margins leading to expectation of net debt to PBILDT above 2.5x on a sustained basis. • Significant fund outflow to group companies, thus impacting its

Agency-reported financials (CARE, 08 Apr 2026)

MetricMarch 31, 2024March 31, 20259MFY26
Total operating income₹2,396 Cr₹2,537 Cr₹1,925 Cr
PBILDT*₹539 Cr₹609 Cr₹443 Cr
Profit after tax (PAT)₹251 Cr₹322 Cr₹238 Cr
Overall gearing (x)0.34×0.26×—
Interest coverage (x)6.40×7.20×11.18×
Revenue growth (YoY)—5.9%—
PAT margin10.5%12.7%12.3%

Borrowings & rated debt

Rated borrowing limits (latest)₹1,234 Cr
Peak rated limits₹3,460 CrJan 2022 · CARE
Limits raised0 times0 new facilities rated
Average remaining tenor1.4 years
Next maturity31 Mar 2028₹794 Cr

Rated limits over time

Facility mix

Maturity ladder

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹934 Cr— AA- (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹300 Cr— A1+ReaffirmedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
—Fund based LT Term Loan FYTerm loans— —31 Mar 2028 ₹794 CrA+ Outstanding

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LC₹300 CrCARE A1+
Cash Credit₹550 CrCARE AA-; Stable
Commercial Paper (Carved out)—Withdrawn
Term Loan₹384 CrCARE AA-; Stable

Lenders

Fund-based - LTCash CreditAxis Bank Ltd.
Fund-based - LTCash CreditCanara Bank
Fund-based - LTCash CreditCentral Bank of India
Fund-based - LTCash CreditDBS Bank Limited
Fund-based - LTCash CreditHDFC Bank Ltd.
Fund-based - LTCash CreditHSBC Ltd.
Fund-based - LTCash CreditStandard Chartered Bank
Fund-based - LTTerm LoanAxis Bank Ltd.
Fund-based - LTTerm LoanFederal Bank
Fund-based - LTTerm LoanHDFC Bank Ltd.
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCCanara Bank
Non-fund-based - STBG/LCCentral Bank of India
Non-fund-based - STBG/LCDBS Bank Limited
Non-fund-based - STBG/LCHDFC Bank Ltd.
Non-fund-based - STBG/LCHSBC Ltd.
Non-fund-based - STBG/LCStandard Chartered Bank

Credit assessment · Cement

CARE Ratings’ Criteria for Rating Cement Companies (Sep 2024) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrongAgency: Strong
DirectionStableAgency outlook: Stable
CARE rating · Apr 2026AA-2 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)77%
Information on file89% · missing: Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 77% (Mostly stable) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹1,234 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage11.18×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 77% chance the next rating action is stable or better
  • Current rating AA- (investment grade)
  • Interest coverage 11.18×

Rated limits by facility

Timeline

08 Apr 2026 CARE reaffirmed: AA- (Stable)Rated limits ₹1,234 cr CARE rationale
08 Apr 2026 Full repayment of term debt
From the report

Limited capex and scheduled repayment of term debt have led to improvement in leverage ratios over the years.

CARE rationale
08 Apr 2026 Capex / project: ₹700 cr
From the report

The company has recently announced greenfield project in Madhya Pradesh with planned daily production capacity of 500 tonnes, at an estimated cost of ₹700 crore and manufacturing of aluminium cans withtotal capex of ₹900-1000 crore.

CARE rationale
08 Apr 2026 Cash & liquid funds ₹600 cr
From the report

Despite the elevated capex, the company’s capital structure is expected to remain comfortable, supported by healthy cash accruals of ~₹500–₹600 crore in FY27–FY28, with net leverage likely to sustain below 1.5x.

CARE rationale
08 Apr 2026 Cash & liquid funds ₹23 cr
From the report

The company has paid ~₹307 crore in FY26 including ₹225 crore as prepayment with their existing cash and bank balances, also company has free cash and bank balance of ₹23 crore as on December 31, 2025, and negligible utilisation of working capital lines. 3 CARE Ratings Ltd.

CARE rationale
08 Apr 2025 CARE upgraded: A1+ (Developing)Rated limits ₹1,234 cr CARE rationale
08 Apr 2025 Capex / project: ₹700 cr
From the report

The company has recently announced greenfield project in Madhya Pradesh with planned daily production capacity of 500 tonnes, at an estimated cost of ₹700 crore.

CARE rationale
08 Apr 2025 Full repayment of term debt
From the report

Limited capex and scheduled repayment of term debt has led to improvement in leverage ratios over the years.

CARE rationale
08 Apr 2025 Cash & liquid funds ₹319 cr
From the report

The company had free cash and cash equivalents of ₹319 crore as on March 31, 2024 and ₹211 crore as on December 31, 2024.

CARE rationale
02 Apr 2024 CARE watch: A+ (Negative)Rated limits ₹1,357 cr CARE rationale
02 Apr 2024 Cash & liquid funds ₹355 cr
From the report

The company had generated gross cash accrual of ₹355 crore in FY23 and is estimate d to generate gross cash accrual of ₹410-₹430 crore in FY24.

CARE rationale
02 Apr 2024 Cash & liquid funds ₹244 cr
From the report

The company had free cash and cash equivalents of ₹244 crore as on March31, 2023 and ₹214 crore as on December 31, 2023.

CARE rationale
02 Apr 2024 Average working-capital utilisation 11%
From the report

Over the past 12 months through January 2024, the average fund-based working capital utilization is 11%, signifying significant cushion.

CARE rationale
27 Mar 2023 CARE watch: A+ (Negative)Rated limits ₹1,357 cr CARE rationale
27 Mar 2023 Full repayment of debt
From the report

The TD/PBILDT increased marginally to 4.11 years as against 3.65 years in FY21 but with improved profitability and repayment of debt, this ratio is expected to improve by FY23 -end to below 3x levels.

CARE rationale
27 Mar 2023 Average working-capital utilisation 58%
From the report

Liquidity: Adequate The average working capital utilization for the 12 months ending on December 31, 2022 stood at 58%, leaving sufficient liquidity buffer.

CARE rationale
27 Mar 2023 Full repayment of loan (₹368 cr)
From the report

AGI Greenpac has also made a prepayment of loan to the extent of ₹368 crore from the ₹591 crore received as proceeds of slump sale of the BPD segment, balance ₹223 crore was utilized to pay the outstanding working capital limits.

CARE rationale
28 Feb 2023 CARE reaffirmed: A+ (Stable)Rated limits ₹1,357 cr CARE rationale
28 Feb 2023 Full repayment of term loan (₹109 cr)
From the report

Out of the total amount Hindware Ltd has paid ₹109 crore in FY22 and balance ₹591 crore has been paid in Q1FY23 which was utilized to prepay term loan to the extent of ₹368 crore and balance ₹223 crore was utilized to pay the outstanding working capital limits.

CARE rationale
28 Feb 2023 Full repayment of debt
From the report

The TD/PBILDT increased marginally to 4.11 years as against 3.65 years in FY21but with improved profitability and repayment of debt, this ratio is expected to improve by FY23-end to below 3x levels.

CARE rationale
28 Feb 2023 Average working-capital utilisation 58%
From the report

Press Release Liquidity: Adequate The average working capital utilization for the 12 months ending on October 31, 2021 stood at 58%, leaving sufficient liquidity buffer.

CARE rationale
28 Feb 2023 Cash & liquid funds ₹53 cr
From the report

Furthermore, the cash and bank balance of the company stood at ₹53 crore as on March 31, 2022 while as on December 31, 2022, it stood at ₹258.74 crore consisting of FDs of ₹213.74 crore and ₹45 crore as bank balance.

CARE rationale
28 Feb 2023 Full repayment of loan (₹368 cr)
From the report

AGI Greenpac has also made a prepayment of loan to the extent of ₹368 crore from the ₹591 crore received as proceeds of slump sale of the BPD segment, balance ₹223 crore was utilized to pay the outstanding working capital limits.

CARE rationale
22 Mar 2022 CARE reaffirmed: A+ (Stable)Rated limits ₹1,730 cr CARE rationale
22 Mar 2022 Average working-capital utilisation 46%
From the report

The company undertaking a capex for increasing its capacity of pipes and faucet division and also involved in doing regular capex and capex to improve its operational efficiency including backward integrati on in Glass and sanitary ware Liquidity: Adequate The average working capital utilization for 12 months ending on December 31, 2021 stood at 46% leaving sufficient liquidity buffer.

CARE rationale
22 Mar 2022 Cash & liquid funds ₹6 cr
From the report

Further, the Cash and Bank Balance of the company stood at Rs.6 Crore a s on March 31, 2021 while as on Nov 30, 2021, it stood at Rs.12.70 crore in form of FDs parked with SBI.

CARE rationale
24 Jan 2022 CARE other: — CARE rationale
04 Jan 2022 CARE reaffirmed: A+ (Stable)Rated limits ₹3,460 cr CARE rationale
04 Jan 2022 Cash & liquid funds ₹23.41 cr
From the report

Cash and Bank Balance of the company stood at Rs.23.41 crore as on March 31, 2021 (PY:Rs. 44.74 crore as on March 31, 2020).

CARE rationale
04 Jan 2022 Average working-capital utilisation 44%
From the report

The average working capital utilization for 12 months ending on Oct 31, 2021 stood at 44% leaving sufficient liquidity buffer.

CARE rationale
26 Jul 2021 CARE reaffirmed: A+ (Stable)Rated limits ₹3,000 cr CARE rationale
26 Jul 2021 Cash & liquid funds ₹23.41 cr
From the report

Cash and Bank Balance of the company stood at Rs.23.41 crore as on March 31, 2021 (PY:Rs. 44.74 crore as on March 31, 2020).

CARE rationale
26 Jul 2021 Average working-capital utilisation 45%
From the report

The average working capital utilization for 12 months ending on May 31, 2021 stood at 45% leaving sufficient liquidity buffer.

CARE rationale
03 Mar 2021 CARE reaffirmed: A+ (Stable)Rated limits ₹1,435.5 cr CARE rationale
03 Mar 2021 Cash & liquid funds ₹44.74 cr
From the report

Cash and Bank Balance of the company stood at Rs. 44.74 crore as on March 31, 2020 while as on Dec 31, 2020 it stood at Rs.28.20 crore.

CARE rationale
03 Mar 2021 Average working-capital utilisation 56.22%
From the report

The average working capital utilization for 12 months ending on September 3 0, 2020 stood at 56.22% leaving sufficient liquidity buffer.

CARE rationale
25 Feb 2021 CARE other: — CARE rationale
27 Feb 2020 CARE reaffirmed: A+ (Stable)Rated limits ₹1,394 cr CARE rationale
27 Feb 2020 New borrowing arranged (commercial paper)
From the report

Outlook: Stable) Short term Bank Facilities 200.00 CARE A1+ Reaffirmed (285.00) (A One Plus) Total 1394.00 (Rupees one Thousand Three Hundred Ninety Four Crore only) Commercial Paper (CP) 100.00 CARE A1+ Issue* (300.00) Reaffirmed (A One Plus) (Rupees One Hundred crore only) *carved out of sanctioned working capital limits of the company Detailed Rationale & Key Rating Drivers The reaffirmation of the ratings assigned to the bank facilities and commercial paper issue of HSIL Limited (HSIL) continues to derive strength from its experienced promoters, its established track record of operations,

CARE rationale
27 Feb 2020 New borrowing arranged (term loans)
From the report

Liquidity: Adequate The liquidity position of the HSIL remains adequate as marked by sufficient unavailed limits in the sanctioned fund based and non-fund based limits of the company and healthy cash accruals generated by the company for meeting the repayment obligations and planned capex funded through internal accruals.

CARE rationale
27 Feb 2020 Cash & liquid funds ₹35.51 cr
From the report

The company is having cash and bank balance of Rs. 35.51 crore as on March 31, 2019 (post demerger).

CARE rationale
28 Jan 2019 CARE reaffirmed: A+ (Stable)Rated limits ₹1,594.4 cr CARE rationale
28 Jan 2019 New borrowing arranged (commercial paper)
From the report

One Thousand five hundred ninety four crore and forty lakhs only) Commercial Paper (CP) 300.00 CARE A1+ Reaffirmed issue* (A One Plus) Details of instruments/facilities in Annexure-1 *carved out of the sanctioned working capital limits of the company.

CARE rationale
28 Jan 2019 New borrowing arranged: ₹570 cr (term loans)
From the report

Furthermore, in order to meet the working capital requirements, the company has sanctioned fund based working capital limits of Rs.570 crore with moderate utilization of 75 - 80% during the last 12 months ending December 2018.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered office2, RED CROSS PLACE, KOLKATA, KOLKATA, IN-WB, 700001
GSTIN—
Email—
Websitehttps://www.agi-greenpac.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of AGI Greenpac

Competitors10identified
Locations3most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Asahi India Glass (AIS) Glass & Glassware · Cement, Building Materials & Polymers aisglass.com — India
Borosil Limited Glass & Glassware · Cement, Building Materials & Polymers borosil.com — Mumbai, Maharashtra, India
La Opala RG Glass & Glassware · Cement, Building Materials & Polymers laopala.in — India
Sejal Glass Limited Glass & Glassware · Cement, Building Materials & Polymers — — Mumbai, Maharashtra, India
Piramal Glass Private Limited Glass & Glassware · Manufacturing (Metals and Chemicals, and products thereof) piramalglass.com — Mumbai, Maharashtra, India
Saint-Gobain Glass & Glassware · Cement, Building Materials & Polymers saint-gobain.co.in — Pune, India
Hindusthan National Glass Glass & Glassware · Cement, Building Materials & Polymers hngil.com — Kolkata, India
Gold Plus Glass Glass & Glassware · Cement, Building Materials & Polymers goldplusglass.com — New Delhi, India
Surbhi Glass Private Limited Glass & Glassware · Cement, Building Materials & Polymers — — Gurugram, Haryana, India
Jagdamba Toughened Glass Private Limited Glass & Glassware · Cement, Building Materials & Polymers — — Gurugram, Haryana, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Glass bottles

Filings

No filings on record yet.